ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:11 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 1149
Drug details and screening numbers
Drug Name: TW 37
Drug ID: 1149
Synonyms:
Brand name:
Target: BCL2, BCL2L1
Number of cell lines screened: 920
Screening concentration range(s): 0.01953125 to 5 uM
Statistically significant associations identified = 4
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a279 |
loss_cnaPANCAN162 |
1149 |
1 |
1 |
TW 37 |
BCL2, BCL2L1 |
23 |
894 |
1.61 |
-0.551 |
0.0822 |
0.634 |
0.54 . |
0.54 . |
0.41 |
2.01e-04 |
7.18e-16 |
5.77e-05 |
12 |
a419 |
loss_cnaPANCAN359_(CUL3) |
1149 |
1 |
1 |
TW 37 |
BCL2, BCL2L1 |
19 |
898 |
1.61 |
-0.552 |
0.25 |
0.803 |
0.68 . |
0.68 . |
0.63 . |
5.14e-04 |
7.93e-16 |
5.87e-05 |
20 |
a425 |
ANK3_mut |
1149 |
1 |
1 |
TW 37 |
BCL2, BCL2L1 |
23 |
894 |
1.61 |
-0.553 |
0.14 |
0.693 |
0.59 . |
0.59 . |
0.55 . |
5.18e-04 |
7.93e-16 |
5.87e-05 |
20 |
a484 |
loss_cnaPANCAN45 |
1149 |
1 |
1 |
TW 37 |
BCL2, BCL2L1 |
37 |
880 |
1.61 |
-0.564 |
0.131 |
0.695 |
0.59 . |
0.59 . |
0.54 . |
6.7e-04 |
8.15e-16 |
5.9e-05 |
23 |
All-tests volcano plot